Omnicell, Inc. (OMCL) |
| 32.43 -0.2 (-0.61%) 09-16 16:00 |
| Open: | 32.79 |
| High: | 33.165 |
| Low: | 32.2 |
| Volume: | 439,344 |
| Market Cap: | 1,475(M) |
| PE Ratio: | 16.98 |
| Exchange: | NASDAQ |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 37.96 |
| Resistance 1: | 35.73 |
| Pivot price: | 33.64 |
| Support 1: | 32.12 |
| Support 2: | 26.72 |
| 52w High: | 55 |
| 52w Low: | 29.06 |
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
| EPS | 0.840 |
| Book Value | 28.320 |
| PEG Ratio | 15.40 |
| Gross Profit | 12.065 |
| Profit Margin (%) | 3.14 |
| Operating Margin (%) | 5.91 |
| Return on Assets (ttm) | 1.5 |
| Return on Equity (ttm) | 3.1 |
Sat, 12 Sep 2026
Precision Trading with Omnicell Inc. (OMCL) Risk Zones - Stock Traders Daily
Thu, 10 Sep 2026
Is Omnicell Inc (OMCL) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
Thu, 03 Sep 2026
A new integration lets hospitals check medicines as they arrive - Stock Titan
Tue, 25 Aug 2026
Omnicell: Offers Good Value, But Uncertainty Remains (NASDAQ:OMCL) - Seeking Alpha
Mon, 03 Aug 2026
Omnicell (OMCL) Is Down 12.5% After Raising 2026 Revenue Outlook And Returning To Profitability - Yahoo Finance
Thu, 30 Jul 2026
Omnicell (OMCL) Stock Trades Down, Here Is Why - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |